KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Biolife Solutions (BLFS) over the last 15 years, with Q3 2025 value amounting to $41000.0.

  • Biolife Solutions' Gains from Investment Securities changed N/A to $41000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $41000.0, marking a year-over-year increase of 11022.44%. This contributed to the annual value of -$4.1 million for FY2024, which is 8577.29% down from last year.
  • Per Biolife Solutions' latest filing, its Gains from Investment Securities stood at $41000.0 for Q3 2025.
  • In the past 5 years, Biolife Solutions' Gains from Investment Securities ranged from a high of $2.3 million in Q3 2022 and a low of -$3.3 million during Q1 2022
  • Over the past 5 years, Biolife Solutions' median Gains from Investment Securities value was -$277500.0 (recorded in 2021), while the average stood at -$287000.0.
  • The largest annual percentage gain for Biolife Solutions' Gains from Investment Securities in the last 5 years was 177571.43% (2022), contrasted with its biggest fall of 57922.61% (2022).
  • Over the past 5 years, Biolife Solutions' Gains from Investment Securities (Quarter) stood at $1.8 million in 2021, then plummeted by 178.59% to -$1.4 million in 2022, then skyrocketed by 70.48% to -$415000.0 in 2023, then skyrocketed by 103.37% to $14000.0 in 2024, then skyrocketed by 192.86% to $41000.0 in 2025.
  • Its last three reported values are $41000.0 in Q3 2025, $14000.0 for Q1 2024, and -$415000.0 during Q4 2023.